The team at Aquarius Population Health investigated the experience of implementing point-of-care tests (POCTs) for paediatric patients during respiratory disease season (winter 2014 – spring 2015), in collaboration with colleagues from three large hospitals in South London (Guy’s and St. Thomas’, King’s College Hospital, and St. George’s University Hospital). Each centre independently evaluated one POCT test (Enigma® MiniLab™ FluAB-RSV PCR assay, BioMérieux BioFire Filmarray, and Luminex RVP Fast v2) on paediatric patients either in the Accident and Emergency department or admitted as an inpatient.
Our managing director, Dr Elisabeth Adams, is presenting two posters at the 30th annual International Papillomavirus Conference in Lisbon, Portugal. The first poster, “Exploring the value of a rapid, on-demand test for the detection of human papillomavirus”, is a detailed look at the current patient pathways for cervical screening programmes, and key opinion leaders’ views on the impact a rapid diagnostic would have on the health and overall wellbeing of women.
Faster answers for better outcomes
Rapid diagnostics are revolutionising the way that clinical decisions are made. Rapid diagnostic technology can yield better results for patients, healthcare providers, and the wider population when introduced in the right way. We can help you understand the options for implementing rapid diagnostics into current care pathways, and can quantify the costs, benefits and impact. This gives you the evidence to support better healthcare delivery.
Straight answers for sensitive questions
As research leaders in sexual health, we have seen our published work impact on international policy and patient care. We have experience in estimating the impact of introducing innovation such as rapid tests into sexual health services, delivering care in new ways, and understanding the burden of disease on society.